pepty

Product focus · Clinician-led program

Tirzepatide.

Tirzepatide (Mounjaro® for type 2 diabetes, Zepbound® for weight management) is a prescription-only medicine that helps control blood sugar in type 2 diabetes and supports significant, sustained weight loss. Any use requires a doctor's prescription and monitoring, and in the Philippines, availability is subject to product registration, medical review, and applicable requirements.

Reviewed August 2026Pepty EditorialPhilippines
Tirzepatide information card: best for sustained weight loss and blood sugar control in type 2 diabetes; also helps with blood pressure, cholesterol, and sleep apnea; not for people with MTC or MEN 2 history or during pregnancy.
Pepty educational information card.

What it's best at

Blood sugar control and significant, sustained weight loss.

Tirzepatide helps control blood sugar in type 2 diabetes and supports significant, long-term weight loss: in clinical studies, many people lost 15–20% or more of their body weight.

Individual results vary, and no outcome is guaranteed. Whether tirzepatide is appropriate at all is a decision for a licensed healthcare professional, made person by person.

Other benefits people often notice

  • Better blood pressure and cholesterol
  • Lower inflammation
  • Improved insulin sensitivity
  • Can reduce symptoms of sleep apnea in people with obesity
  • May help with certain heart conditions linked to excess weight

Fit and contraindications

Who it may suit, and who it never should.

Usually for

Adults it may suit

  • Adults with type 2 diabetes who need better blood sugar control
  • Adults with obesity, or who are overweight and have related health issues (such as high blood pressure, high cholesterol, or sleep apnea)

Suitability is always determined by a doctor, never assumed from a list.

Should not use

Who should not use it

  • Anyone with a personal or family history of a rare thyroid cancer called medullary thyroid carcinoma (MTC)
  • People with a genetic condition called MEN 2
  • Anyone who has had a serious allergic reaction to tirzepatide
  • Pregnant women: it is not recommended during pregnancy and should be stopped well before trying to conceive
  • People with a history of pancreatitis or serious stomach problems should talk carefully with their doctor first

Common side effects

Mostly stomach-related, usually temporary.

Most people experience some stomach-related effects, especially when starting or increasing the dose. These usually improve over time.

Nausea

Most common when starting or increasing the dose.

Vomiting

Usually settles as the body adjusts.

Diarrhea or constipation

Stomach-related effects are the most frequent.

Stomach pain

Report persistent pain to the responsible clinician.

Reduced appetite

Part of how the medicine works: monitor nutrition.

Injection-site reactions

Mild redness or irritation is possible.

More serious but less common issues can include gallbladder problems, low blood sugar (especially if taking insulin), or dehydration. Side-effect reports in a Pepty program route to the responsible clinician through defined escalation workflows.

Honest uncertainty

What we still don't fully know.

Responsible care means saying plainly what is not yet settled. Tirzepatide is well studied, and still has open questions:

  • How it affects thyroid cancer risk in humans over many years: animal studies raised a concern, but human data so far has not shown a clear increase.
  • The absolute long-term safety picture beyond 5–10 years.
  • How much of the weight and health benefits people keep after stopping the medication: many regain a significant portion of the weight.
  • The best long-term plan for staying on or tapering off the medicine.

This is why monitoring, check-ins, and doctor-led follow-up are built into every Pepty-supported program, and why no product is offered simply because demand exists.

Tirzepatide is a prescription-only medicine.

It must be prescribed and monitored by a doctor. This page is educational information only. It is not medical advice, and it does not recommend treatment for any individual.

How clinician-led care worksThe Pepty Platinum Standard

Questions about tirzepatide

Is tirzepatide available through Pepty?

Tirzepatide is the focus of a proposed clinician-led program for appropriate patients, subject to prescription, product registration, medical review, and applicable Philippine requirements. It is prescription-only, and any decision to use it belongs to a licensed healthcare professional and the patient, never to an operator, trainer, or front desk.

Is this page medical advice?

No. This page is educational information for qualified business operators and the public. It does not recommend treatment for any individual. Tirzepatide must be prescribed and monitored by a doctor, and questions about whether it is appropriate belong in a consultation with a licensed healthcare professional.

Do the benefits apply to everyone?

No. Individual results vary, and no outcome is guaranteed. The benefits described here reflect findings from clinical studies and commonly reported effects; whether tirzepatide is appropriate at all (and what results might look like) is a clinical decision made person by person.

The First 50

For the people who want to get this right.

Apply for the first Pepty workshop and learn what it takes to build a responsible peptide program in the Philippines.

Apply for a Workshop Seat

Applications are reviewed for fit, readiness, and commitment to responsible care.